易成新能(300080.SZ)擬收購平煤隆基30%的股權 11月7日起復牌
格隆匯11月6日丨易成新能(300080.SZ)公佈,公司擬向首山化工以發行股份及可轉換債券的方式購買其持有的平煤隆基30%的股權,並向不超過5名符合條件的特定投資者發行股份及/或可轉換債券募集配套資金。
鑑於本次交易標的預估值和定價尚未確定,此次交易中對交易對方的股份、可轉換債券支付比例和支付數量尚未確定,將在對交易標的的審計、評估工作完成之後,由交易各方協商確定,並將在重組報告書中予以披露。
此次交易系收購公司控股子公司的少數股權,此次交易完成後,公司主營業務不會發生變化。
經公司申請,公司股票將於2019年11月7日上午開市起復牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.